In current single-blinded randomized clinical trial, 20 diabetic patients with Bell’s palsy aged greater than 18 years old, will be undergone treatment by low level laser therapy, to evaluate treatment efficacy. Pregnant patients, whom decline to undergo electromyography (EMG) or nerve conduction velocity (NCV) examinations, and patients suffering cancer, will be excluded. Patients will be examined in terms of facial nerve palsy grading and subsequently will undergo EMG and NCV tests, in order to evaluate muscles function (frontalis, orbicularis oris, orbicularis oculi) and axonal injury severity (frontalis, orbicularis oris, orbicularis oculi), respectively.
Using sealed envelope method, patients will be randomly assigned to two groups: study group (10 patients) will receive 12 sessions of low level laser therapy during one month, where control group (10 patients) will not.
At the end, patients will be worked up to evaluate recovery grade after treatment and one month later, by NCV and EMG tests.
Neurologist who will perform EMG and NCV tests will be blinded to patients allocated group.